Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our first review on progress and prospects in cystic fibrosis (CF) gene therapy was published in this series in October 2002. We now summarize the progress made since then and comment on the prospects for CF gene therapy over the next couple of years. Three clinical trials have been carried out, further supporting the proof-of-principle that gene transfer to the airway epithelium is feasible. Developments in viral and non-viral vectors, as well as recent alternative strategies such as gene repair, trans-splicing and stem cell therapy will be reviewed.

Original publication

DOI

10.1038/sj.gt.3302809

Type

Journal article

Journal

Gene Ther

Publication Date

07/2006

Volume

13

Pages

1061 - 1067

Keywords

Adenoviridae, Clinical Trials as Topic, Cystic Fibrosis, Dependovirus, Forecasting, Gene Transfer Techniques, Genetic Therapy, Genetic Vectors, Humans, Respiratory Mucosa, Stem Cells